|
Case Number
|
Title
|
Non-Confidential Summary
|
Issued Patent
|
Lead Inventor's Website
|
|
AKS_EDI.001
|
Modification of Western Blotting Procedure to Generate a Higher Quantitative Data Output with Reduced Errors
|
NCS for AKS_EDI.001 |
|
|
|
ALN_EMA.023
|
The ASC Supramolecular Assembly Complex (ASC SMAC), Compositions for Making and Using the Same
|
NCS for ALN_EMA.023 |
|
Link
|
|
BLO_TIM.014
|
A Serum Protein Marker for Diagnosing Liver Trauma and Hepatocellular Carcinoma
|
NCS for BLO_TIM.014 & FEI_MAR.003 |
|
|
|
BRO_JON.001
|
The Specific Level of Expression and Localization of a Key Signaling Protein Can Dictate And Predict The Response Of The Most Commonly Used Chemotherapeutic Used In The Treatment Against Pancreatic Cancer, Ovarian Cancer And Metastatic Breast Cancer
|
NCS for BRO_JON.001 |
|
Link
|
|
CRO_CAR.002
|
Compositions, Kits and Methods Relating to the Human FEZ1 Gene, a Novel Tumor Suppressor Gene
|
NCS for Croce tumor suppressor techs (CRO 2,4,5,16) |
|
|
|
CRO_CAR.004
|
The Human FHIT Gene
|
NCS for Croce tumor suppressor techs (CRO 2,4,5,16) |
[United States Patent: 7220834] [United States Patent: 6774217] [United States Patent: 6242212] [United States Patent: 5928884]
|
|
|
CRO_CAR.009
|
TCL-1 Gene And Protein And Related Methods And Compositions
|
NCS for Croce TCL-1 techs (CRO 9,15) |
|
|
|
CRO_CAR.010
|
Detection of Hematogenous Micrometastasis in Patients With Prostate Cancer
|
|
[US Patent No. 5,506,106] [US Patent No. 5,674,682] [US Patent No. 5,688,649] [US Patent No. 5,939,258]
|
|
|
CRO_CAR.015
|
Human Chronic Lymphocytic Leukemia Modeled in Mouse by Targeted TCL1 Expression
|
NCS for Croce TCL-1 techs (CRO 9,15) |
|
|
|
CRO_CAR.016
|
Novel Tumor Suppressor Gene and Compositions and Methods for Making and Using the Same
|
NCS for Croce tumor suppressor techs (CRO 2,4,5,16) |
|
|
|
CRO_CAR.017
|
Role of microRNA Genes In Human Cancer
|
NCS for Croce miRNA techs (CRO 17, 25) |
|
|
|
CRO_CAR.019
|
Involvement Of The ALL-1 Gene In A Solid Tumor1
|
|
[US Patent No. 5,567,586]
|
|
|
CRO_CAR.025
|
microRNA genes in cancer diagnosis and treatment
|
NCS for Croce miRNA techs (CRO 17, 25) |
|
|
|
DAN_REN.005
|
Methods to Measure Frequency of Integration in the Vicinity of Active Genes
|
|
|
Link
|
|
DIE_BER.011
|
In Vitro Potency Test for Rabies Vaccines
|
|
|
Link
|
|
FEL_ART.001
|
Adenosine A1 Receptor Mutations Predict Infarct Size
|
NCS for FEL_ART 001, 003 |
|
Link
|
|
KWO_SIM.001
|
Novel Tumor Suppressor Encoding Nucleic Acid, PTX1, and Methods of Use Thereof
|
NCS for KWO_SIM.001 |
[US Patent No. 6,743,603]
|
|
|
LIS_MIC.002
|
Role of CAPER in Breast Cancer
|
NCS for LIS_MIC.002 |
|
Link
|
|
MAH_MYG.001
|
Anti-Desmoglein 1-B Antibodies
|
NCS for MAH_MYG.001 |
|
Link
|
|
PES_CES.001
|
Compositions And Methods For Use In Affecting Hematopoietic Stem Cell Populations In Mammals
|
|
[US Patent No. 6,586,192]
|
|
|
SHA_KUM.013
|
Treatment of kidney disease with the Hormone Adiponectin
|
NCS for SHA_KUM.013 |
|
|
|
SYK_YUR.004
|
Invention of a Novel Serum Free Media for Cultivation of Hybridoma Cells to Achieve Production of Highly Homogenous Monoclonal Antibodies (MAb) in Preparative Scale
|
|
|
Link
|
|
TEC_UDO.001
|
An Efficient Distortion Correction Method In EPI
|
NCS for TEC_UDO 001 |
|
|
|
THA_MAT.001
|
Radiolabeled Vasoactive Intestinal Peptide Analogs for Localizing Tumors
|
NCS for THA_MAT.001 & 011 |
[US Patent No. 6,395,255] [US Patent No. 6,824,759]
|
Link
|
|
THA_MAT.002
|
Lipid soluble radioactive metal chelates for tumor therapy
|
NCS for THA_MAT.002 |
[US Patent No. 6,685,913]
|
Link
|
|
WIC_ERI.006
|
Quencher-Free Molecular Beacons
|
NCS for WIC_ERI 006 |
|
Link
|
|
WON_ALB.005
|
The Rapid Identification of Alternative Splicing (RIAS) Method
|
|
|
|